XARTEMIS™ XR is the first and only FDA-approved combination of oxycodone and acetaminophen to provide immediate- and extended-release analgesia.¹

• Delivers onset of pain relief in less than an hour and lasts up to 12 hours with a predictable pharmacokinetic profile.^1,3
  • In the clinical trial, supplemental analgesia was available to patients in the XARTEMIS XR and placebo groups.¹
  • Supplemental ibuprofen was used by less than 50% of the XARTEMIS XR-treated patients after the first dose interval.¹
• Simple dosing—2 tablets, twice daily.¹
  • On the first day of treatment, the second dose may be taken at 8 hours after initial dose if pain intensity requires it.
  • Contains 7.5 mg of oxycodone HCl and 325 mg of acetaminophen per tablet.

IMPORTANT RISK INFORMATION

XARTEMIS XR tablets should be swallowed whole one at a time, with enough water to ensure complete swallowing immediately after placing in mouth. Do not break, chew, crush, cut, dissolve or split the tablets.